Recent Finacing
Recent Raise
CNS Therapeutics develops intrathecal drug therapies delivered via implanted pumps, commercializing FDA‑approved Gablofen (baclofen) for severe spasticity and pursuing intrathecal treatments for pain and Parkinson’s.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors